Eli Lilly (LLY) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)

Eli Lilly (LLY) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 25.19%
Dec 31, 2025 23.23%
Sep 30, 2025 21.93%
Jun 30, 2025 20.80%
Mar 31, 2025 18.53%
Dec 31, 2024 16.78%
Sep 30, 2024 15.70%
Jun 30, 2024 13.57%
Mar 31, 2024 11.86%
Dec 31, 2023 10.06%
Sep 30, 2023 6.12%
Jun 30, 2023 5.16%
Mar 31, 2023 3.32%
Dec 31, 2022 2.82%
Sep 30, 2022 1.61%
Jun 30, 2022 1.24%
Mar 31, 2022 1.56%
Dec 31, 2021 1.72%
Sep 30, 2021 1.57%
Jun 30, 2021 1.88%